Marel Q2 2019: On track with solid sales and EBIT growth
24 juil. 2019 12h40 HE
|
Marel hf.
Financial highlights Q2 2019 Orders received were EUR 311.2m (2Q18: 291.1m).Revenues were EUR 326.5m (2Q18: 296.7m).Adjusted EBIT* was EUR 49.6m (2Q18: 43.2m), translating to an EBIT* margin of...
Marel: Kynningarfundur með fjárfestum 2019
02 mai 2019 07h40 HE
|
Marel hf.
Í dag, 2. maí, 2019, heldur Marel kynningarfund með fjárfestum og markaðsaðilum í nýsköpunar- og framleiðslustarfsstöð félagsins í Boxmeer, Hollandi. Þar munu lykilstjórnendur Marel flytja...
Marel: Capital markets day 2019 presentation
02 mai 2019 07h40 HE
|
Marel hf.
Today, 2 May 2019, Marel is hosting its 2019 Capital markets day at the company’s manufacturing and innovation facilities in Boxmeer, the Netherlands. Marel´s senior management will give...
Marel: Ársuppgjör 2018 birt 6. febrúar, fjárfestafundur 7. febrúar 2019
23 janv. 2019 09h00 HE
|
Marel hf.
Marel hf. mun birta ársuppgjör 2018 eftir lokun markaðar þann 6. febrúar 2019. Fundur með markaðsaðilum Fimmtudaginn 7. febrúar 2019 kl. 8:30 verður haldinn afkomufundur með markaðsaðilum og...
Marel: 2018 financial results published 6 February, investor meeting on 7 February, 2019
23 janv. 2019 09h00 HE
|
Marel hf.
Marel hf. will publish its 2018 annual consolidated financial statements after market closing on 6 February 2019. Investor meeting and webcast On Thursday 7 February 2019, at 8:30 am (GMT),...
TLC to Attend Goldman Sachs Asia Pacific Healthcare Forum 2018
25 nov. 2018 06h00 HE
|
Taiwan Liposome Company, Ltd.
TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Nov. 25, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated...
Assembly Biosciences to Present at Cowen’s 38th Annual Healthcare Conference
05 mars 2018 07h00 HE
|
Assembly Biosciences, Inc.
INDIANAPOLIS, March 05, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
Assembly Biosciences to Participate in Leerink Partners 7th Annual Global Healthcare Conference
05 févr. 2018 07h05 HE
|
Assembly Biosciences, Inc.
INDIANAPOLIS, , Feb. 05, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
Assembly Biosciences to Present at the J.P. Morgan Healthcare Conference
04 janv. 2018 07h05 HE
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
Assembly Biosciences to Present at the Jefferies London Healthcare Conference
08 nov. 2017 07h00 HE
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...